Abstract
The transforming growth factor-beta (TGF-β) superfamily members play diverse roles in cartilage development and maintenance. TGF-β up-regulates chondrogenic gene expression by enhancing transcription factor SRY (sex determining region Y)-box 9 (Sox9) and inhibits osteoblast differentiation by repressing runt-related transcription factor 2 (Runx2). Recently, histone deacetylases (HDACs) were reported to act as negative regulators of chondrocyte hypertrophy. It was speculated that HDAC4 may promote TGF-β1-induced MSC chondrogenesis. In this study, the adenovirus-mediated HDAC4 gene (Ad.HDAC4) was utilized to infect synovium-derived stem cells (SDSCs). Adenovirus-mediated LacZ (Ad.LacZ) served as a control. The infected cells were centrifuged to form SDSC pellets followed by incubation in a serum-free chondrogenic medium for 15 days with or without 10 ng/mL TGF-β1. Transfection efficiency was determined in SDSCs using Ad.LacZ. Cytotoxicity was measured using lactate dehydrogenase assay. Histology, immunostaining, biochemical analysis, and real-time polymerase chain reaction were performed to assess chondrogenesis at protein and mRNA levels in infected SDSCs. Our data demonstrated that supplementation with TGF-β1 could initiate and promote SDSC chondrogenesis; however, TGF-β1 alone was insufficient to fully differentiate SDSCs into chondrocytes. Ad.HDAC4 could be efficiently transfected into SDSCs. Without TGF-β1 treatment, HDAC4 had no effect on SDSC chondrogenesis; however, in the presence of TGF-β1, HDAC4 could speed up and maintain a high level of chondrogenesis while down-regulating the hypertrophic marker – type X collagen expression. This study is the first report showing that HDAC4 overexpression promotes TGF-β1-induced SDSC chondrogenesis but inhibits chondrogenically differentiated stem cell hypertrophy. The mechanism underlying this process needs further investigation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have